Search

Progyny Inc

Fermé

SecteurSoins de santé

25.57 0.59

Résumé

Variation du prix de l'action

24h

Actuel

Min

25.31

Max

25.8

Chiffres clés

By Trading Economics

Revenu

28M

52M

Ventes

22M

351M

P/E

Moyenne du Secteur

28.461

57.371

BPA

0.34

Marge bénéficiaire

14.917

Employés

835

EBITDA

5.9M

44M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+33.72% upside

Dividendes

By Acuity

Prochains Résultats

5 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-495M

1.9B

Ouverture précédente

24.98

Clôture précédente

25.57

Sentiment de l'Actualité

By Acuity

51%

49%

283 / 340 Classement par Healthcare

Progyny Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 août 2026, 19:36 UTC

Progyny Inc shares are lower today, reversing from earlier gains amid market volatility linked to geopolitical tensions and US sanctions against Iran.

20 août 2026, 19:31 UTC

News

Wells Fargo initiated coverage on Progyny Inc with an Overweight rating and a $37.00 price target, contributing to the stock's rise during Thursday's session.

18 août 2026, 20:06 UTC

Progyny Inc. shares are higher today, reflecting steady gains during the session. The stock remains below its 20-day moving average.

17 août 2026, 20:01 UTC

News

Progyny Inc shares are lower following a negative market reaction to its second-quarter earnings and lowered full-year revenue guidance to $1.37 billion.

14 août 2026, 20:06 UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

13 août 2026, 21:31 UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

12 août 2026, 20:01 UTC

News

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11 août 2026, 20:02 UTC

News

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7 août 2026, 20:02 UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6 août 2026, 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 juil. 2026, 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 juil. 2026, 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 juil. 2026, 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 juil. 2026, 17:41 UTC

News
Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 juil. 2026, 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 juil. 2026, 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 juil. 2026, 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Comparaison

Variation de prix

Progyny Inc prévision

Objectif de Prix

By TipRanks

33.72% hausse

Prévisions sur 12 Mois

Moyen 34.3 USD  33.72%

Haut 40 USD

Bas 30 USD

Basé sur 10 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

10 ratings

8

Achat

2

Maintien

0

Vente

Sentiment

By Acuity

283 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat